DATALEND TRENDING - AUGUST 27, 2014


 

$GTAT

GT ADVANCED TECHNOLOGIES

$ONVO

Organovo

$VNDA

VANDA PHARMACEUTICALS

Utilization     94.89% 96.72% 86.98%
Short Interest 48.05%

17.44%

22.65%
Days to Cover 7.08 15.95 11.98
Fees to Borrow*
Down Down Down
*Since Previous Trading Day


SECURITIES LENDING TOP 10 EARNING EQUITIES - AUGUST 21, 2014


Methodology: We scan our universe of more than 42,000 securities on loan to find those securities with the most expensive financing positions in the U.S., U.K., Europe and Asia. Financing costs are determined by taking the total on-loan value of a security and multiplying it by the volume-weighted average fees to borrow that security, then converting the product of those numbers to a dollar value. We then sort the most expensive securities to finance in the securities lending market in descending order.

US

Utilization

1     3D SYSTEMS 93.00%
2     GOPRO CL A 97.05%
3     VIRNETX HOLDING 90.50%
4     GT ADVANCED TECHNOLOGIES 94.61%
5     MANNKIND 94.93%
6     PLUG POWER 86.02%
7     MEDIA GENERAL 92.50%
8     THERAVANCE 91.75%
9     TEXTURA 65.50%
10   CLIFFS NATURAL RESOURCES 93.99%


UK

Utilization

1     QUINDELL 92.31%
2     JSC VTB BANK GDR 66.02%
3     MONITISE 84.14%
4     HSBC STK Q 91.82%
5     ASHMORE GROUP 82.57%
6     GLENCORE 14.36%
7     ROYAL DUTCH SHELL CL A 7.33%
8     BP

2.99%

9    SAGA 70.04%
10   GULF KEYSTONE PETROLEUM 92.97%



Europe

Utilization

1     GEMALTO (NL) 88.22%
2     STATOIL (NO) 60.87%
3     QUINDELL 92.31%
4     ROYAL DUTCH SHELL CL A (NL) 26.32%
5     ELEKTA B (SE) 74.69%
6     CHINA VANKE H 56.25%
7     FIAT (IT) 51.44%
8     NORWEGIAN AIR SHUTTLE (NO) 91.05%
9     ALPHA BANK R (GR) 33.52%
10   OUTOTEC (FI) 70.95%



Far East/Australia Pacific

Utilization

1     ANHUI CONCH H (HK) 75.58%
2     GUNGHO ONLINE (JP) 86.87%
3     HANERGY SOLAR (HK) 85.24%
4     EVERGRANDE (HK) 77.83%
5     MIXI (JP) 97.09%
6     CELLTRION (KR) 71.83%
7     GREE (JP) 90.80%
8     SANRIO (JP) 89.66%
9     HUISHAN DAIRY 65.93%
10   SUNART RETAIL (HK) 73.44%


This is just a snapshot of the rich data and functionalities provided by DataLend. Click here for more information about DataLend's key features.



THE INFORMATION CONTAINED HEREIN IS PROPRIETARY TO EQUILEND; MAY NOT BE COPIED OR DISTRIBUTED WITHOUT THE EXPRESS CONSENT OF EQUILEND; SHALL NOT CONSTITUTE INVESTMENT ADVICE BY EQUILEND, OR ANY REPRESENTATIVE THEREOF; IS NOT WARRANTED TO BE ACCURATE, COMPLETE OR TIMELY; IS PROVIDED FOR INFORMATIONAL PURPOSES ONLY; IS NOT INTENDED FOR TRADING PURPOSES; AND SHOULD NOT BE CONSTRUED AS EQUILEND MAKING FORECASTS, PROJECTING RETURNS OR RECOMMENDING ANY PARTICULAR COURSE OF ACTION. NEITHER EQUILEND NOR ANY REPRESENTATIVE THEREOF SHALL BE AN ADVISOR OR A FIDUCIARY OF A VISITOR TO THIS WEBSITE. EQUILEND IS NOT RESPONSIBLE OR LIABLE IN ANY WAY TO THE READER OR VISITOR, OR TO ANY PERSON, FIRM OR CORPORATION FOR ANY DAMAGES OR LOSSES ARISING FROM ANY USE OF THE INFORMATION CONTAINED HEREIN. IN CONSIDERING THE INFORMATION CONTAINED HEREIN, A VISITOR TO THIS WEBSITE DOES SO SOLELY IN RELIANCE ON THE VISITOR’S OWN JUDGMENT. PAST PERFORMANCE IS NO GUARANTEE OF FUTURE PERFORMANCE.

DATALEND ALERTS

Sign up for weekly DataLend Top 10 email alerts



DATA ARCHIVE

August 21, 2014

July 24, 2014

June 26, 2014

June 19, 2014

June 12, 2014

June 5, 2014

May 29, 2014

May 22, 2014

May 16, 2014

May 8, 2014

May 1, 2014

April 25, 2014

April 11, 2014

April 4, 2014

March 20, 2014

March 13, 2014

March 7, 2014

February 27, 2014

February 20, 2014

February 7, 2014

January 31, 2014

January 24, 2014

January 9, 2014

December 12, 2013

December 6, 2013

November 27, 2013

November 15, 2013

November 8, 2013

October 31, 2013

October 24, 2013

October 18, 2013

October 10, 2013

October 3, 2013

September 27, 2013

September 20, 2013

September 12, 2013

September 5, 2013

August 30, 2013

August 23, 2013

August 15, 2013

August 9, 2013

August 2, 2013

July 26, 2013

July 19, 2013

July 12, 2013